Acanthocytosis in an alectinib‐treated patient
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18020
Abstract: An 85- year- old woman who was being treated for an ALK-positive bronchial adenocarcinoma with alectinib, an ALK (anaplastic lymphoma kinase) inhibitor, was hospitalised with a pulmonary embolus. She was found to have a haemoglobin… read more here.
Keywords: alectinib treated; alectinib; treated patient; acanthocytosis alectinib ... See more keywords